《MedRxiv,3月6日,Case fatality risk of novel coronavirus diseases 2019 in China》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-07
  • Case fatality risk of novel coronavirus diseases 2019 in China

    Xiaowei Deng, Juan Yang, Wei Wang, Xiling Wang, Jiaxin Zhou, Zhiyuan Chen, Jing Li, Yinzi Chen, Han Yan, Juanjuan Zhang, Yongli Zhang, Yan Wang, Qi Qiu, Hui Gong, Xianglin Wei, Lili Wang, Kaiyuan Sun, Peng Wu, Marco Ajelli, Benjamin J. Cowling, Cecile Viboud, Hongjie Yu

    doi: https://doi.org/10.1101/2020.03.04.20031005

    Abstract

    Objective The outbreak of novel coronavirus disease 2019 (COVID-19) imposed a substantial health burden in mainland China and remains a global epidemic threat. Our objectives are to assess the case fatality risk (CFR) among COVID-19 patients detected in mainland China, stratified by clinical category and age group. Method We collected individual information on laboratory-confirmed COVID-19 cases from publicly available official sources from December 29, 2019 to February 23, 2020. We explored the risk factors associated with mortality. We used methods accounting for right-censoring and survival analyses to estimate the CFR among detected cases.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.03.04.20031005v1
相关报告
  • 《MedRxiv,3月6日,Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-07
    • Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China Min Cao, Dandan Zhang, Youhua Wang, Yunfei Lu, Xiangdong Zhu, Ying Li, Honghao Xue, Yunxiao Lin, Min Zhang, Yiguo Sun, Zongguo Yang, Jia Shi, Yi Wang, Chang Zhou, Yidan Dong, Ping Liu, Steven M Dudek, Zhen Xiao, Hongzhou Lu, Longping Peng doi: https://doi.org/10.1101/2020.03.04.20030395 Abstract Background: Since mid-December 2019, a cluster of pneumonia-like diseases caused by a novel coronavirus, now designated COVID-19 by the WHO, emerged in Wuhan city and rapidly spread throughout China. Here we identify the clinical characteristics of COVID-19 in a cohort of patients in Shanghai. Methods: Cases were confirmed by real-time RT-PCR and were analysed for demographic, clinical, laboratory and radiological features. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《MedRxiv,3月6日,Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-07
    • Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province Hui Wan, Jing-an Cui, Guo-Jing Yang doi: https://doi.org/10.1101/2020.03.01.20029629 Abstract Background: In December 2019, an outbreak of novel coronavirus disease (COVID-19) emerged in Wuhan, China and has swiftly spread to other parts of China and a number of oversea countries. Our aim is to evaluate the effectiveness of the evolution of interventions and self-protection measures, estimate the risk of partial lifting control measures and predict the epidemic trend of the virus in mainland China excluding Hubei province based on the published data and a novel mathematical model. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.